Genomcore
PrivateLast Round
VC Round
Dec 2, 2024
Total Funding Raised
$1.04M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Genomcore operates in Healthcare & Life Sciences and is based in Esplugues de Llobregat. Its latest recorded funding round was a VC Round in December 2024.
Genomcore is a biotechnology company that provides a modular platform for biomedical data management, enabling the integration and analysis of genomic, clinical, and sensor data for precision medicine applications.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Platform-as-a-Service, Low-Code/No-Code, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Services & Consulting, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomcore Comparables
Compare Genomcore with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DNAnexus | 80% | |
| SeqOne | 79% | |
| BC Platforms | 77% |
For institutional investors. Book with your work email.
Genomcore Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 2, 2024 | ||||
| Grant | Oct 17, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genomcore Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QVIDTVM Management | VC Round |
| Barça Innovation Hub | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 48% MoM.
- Dec 2, 2024
$5.25M round led by QVIDTVM Management
For institutional investors. Book with your work email.
Genomcore Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genomcore's valuation, stock price, and market status.
Is Genomcore a public or private company?
Genomcore is a private company.
What is the current stock price of Genomcore?
Genomcore is a private company, so its shares have no public market price. Caplight tracks Genomcore's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genomcore worth (valuation)?
Valuation information for Genomcore is not publicly available.
Can I buy Genomcore stock?
Genomcore shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genomcore's last funding round?
Genomcore's most recent funding round was VC Round on December 2, 2024.
Who are the main investors in Genomcore?
Key investors in Genomcore include QVIDTVM Management.
Will Genomcore IPO soon?
No public IPO plans have been announced for Genomcore.
How can I track Genomcore secondary market activity?
Caplight tracks bids, offers, and trades in Genomcore's shares on secondary markets.